NOVEL DELIVERY ROUTES FOR GLP-1 Oral semaglutide is the first noninjectable formulation of a GLP-1 receptor agonist approved by the U.S
When determining the maximum discharge current, it is necessary to multiply the rated value of C by the battery capacity
In addition to type 2 diabetes, severe obesity can also lead to other chronic diseases such as heart disease or some types of cancer [14]
10.1038/nrneph.2016.145 44
Coverage for GLP-1 medications specifically varies significantly by insurer, plan type, and diagnosis
The intestinal homeostasis, which is the healthy and balanced state of the intestine, is determined by the intestinal epithelium, the gut microbiome, and the host immune system